SGX Stocks :: Your One Stop SGX Stocks Info Blog

• Revenue: +38.4% (2Q09), +35.9% (1H09)
• Net Profit: +6.6% (2Q09), +10.4% (1H09)
• Outlook: The Group expects the operating environment for the second half of 2009 to remain challenging.
• Government investment in public healthcare is expected to continue to drive growth in the Chinese healthcare and pharmaceutical sectors.
• The Chinese government has yet to announce its blueprint for healthcare reforms in China and we are awaiting further details to assess the impact on our business model and earnings in 2009.
• The Group remains alert to any policy changes and will respond quickly as needed.

FINANCIAL RECORDS

Revenue (RMB '000)

FY 1Q 2Q 3Q 4Q Total
2009 143,265 179,129
2008 107,922 129,384 128,771 143,971 510,048
2007 50,096 66,274 71,669 98,310 286,349
2006 34,355 35,916 39,072 52,433 161,776
2005 NA NA NA NA 101,615
-----------------------------------------------------------
Earnings (RMB '000)

FY 1Q 2Q 3Q 4Q Total
2009 60,990 64,688
2008 53,106 60,684 66,519 56,750 237,059
2007 32,023 51,122 43,493 52,628 179,266
2006 18,664 20,631 19,582 31,576 90,453
2005 NA NA NA NA 38,215
-----------------------------------------------------------
Dividends (RMB)

FY Interim Final Special
2009 NA
2008 NA 0.153 NA
2007 NA 0.130 NA
-----------------------------------------------------------
Bonus Issue / Stock Split

Date Type Details
NA
-----------------------------------------------------------
Share Data (RMB)

NAV = $1.6196
EPS = $0.2674 (6M FY09)
No of Shares = 470,000,000
-----------------------------------------------------------

ANALYSTS' TARGET PRICES

Broker Recommendation Target Price Date
NA